Ethical and safety aspects of clinical trials in neonates

Imti Choonara1

  • 1Academic Division of Child Health, University of Nottingham, Derbyshire Children's Hospital, Derby DE22 3DT, UK. imti.choonara@nottingham.ac.uk

Early Human Development
|September 25, 2009
PubMed

Insights

Clinical trials in neonates are crucial for establishing drug efficacy and safety. New European legislation aims to boost neonatal research, leading to more licensed medicines and emphasizing safe, ethical trial practices.

Area of Science:

  • Neonatal pharmacology
  • Pediatric clinical research
  • Drug safety and efficacy

Background:

  • Clinical trials in neonates are vital for evidence-based medicine.
  • Recent European legislation aims to increase research in this population.
  • Understanding neonatal drug toxicity is critical for safe trials.

Purpose of the Study:

  • To highlight the importance of clinical trials in neonates.
  • To discuss the impact of new European legislation on neonatal drug research.
  • To emphasize the need for awareness of factors predisposing neonates to drug toxicity.

Main Methods:

  • Review of European legislation concerning pediatric drug development.
  • Analysis of the importance of neonatal clinical trials.
  • Discussion of predisposing factors for drug toxicity in neonates.

Main Results:

  • European legislation is expected to stimulate more clinical research in neonates.
  • Increased research may lead to a greater number of licensed medicines for neonatal use.
  • Awareness of specific neonatal vulnerabilities is essential for safe and ethical trial conduct.

Conclusions:

  • Clinical trials in neonates are indispensable for ensuring drug safety and efficacy.
  • New legislative initiatives are poised to enhance the landscape of neonatal medicine.
  • Prioritizing safe and ethical trial conduct, including understanding toxicity factors, is paramount.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Ethical Dilemmas I01:17

Ethical Dilemmas I

Ethical dilemmas in nursing are of utmost importance, as they often arise from the tension between adhering to core ethical principles and the practical realities of healthcare delivery. These dilemmas require nurses to navigate complex situations where competing ethical considerations pull them in different directions.
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...